Phospho-H3F3A (S31) Antibody

What is H3F3A and why is the S31 phosphorylation site significant?

H3F3A, also known as Histone H3.3, is a variant histone that replaces conventional H3 in a wide range of nucleosomes in active genes. Unlike canonical H3 (H3.1/H3.2), H3.3 constitutes the predominant form of histone H3 in non-dividing cells and is incorporated into chromatin independently of DNA synthesis. The serine 31 (S31) residue is evolutionarily conserved and unique to H3.3, as canonical H3 histones contain an alanine at this position. S31 phosphorylation represents a specific post-translational modification that occurs primarily during mitosis, particularly in late prometaphase and metaphase, making it a valuable marker for these cell cycle stages .

How does H3.3 S31 phosphorylation differ from other histone H3 phosphorylation events?

H3.3 S31 phosphorylation exhibits distinct temporal and spatial patterns compared to other histone H3 phosphorylation events. While common phosphorylation sites like H3 S10 and H3 S28 become phosphorylated early in prophase and remain phosphorylated through anaphase, H3.3 S31 phosphorylation is initiated later during late prometaphase, peaks in metaphase, and is minimal in very early (prophase and early prometaphase) and late mitotic stages (anaphase and telophase) . Additionally, immunofluorescence studies show that H3.3 S31P exhibits speckled staining in the dense region of the metaphase plate, while H3 S10P/S28P localize to different regions of mitotic chromatin, suggesting distinct functions .

How is the specificity of Phospho-H3F3A (S31) antibodies validated?

Validation of Phospho-H3F3A (S31) antibodies typically employs multiple techniques:

• Peptide competition assays: Synthetic peptides containing phosphorylated S31 should compete away antibody binding, while non-phosphorylated peptides should not. In one validation study, only the H3.3 S31P peptide fully competed away the H3.3 S31P antibody signal on mitotic HeLa histones .

• Reverse-phase HPLC separation: H3 variants can be separated and individually tested with the antibody to confirm isoform specificity. Tests demonstrated that H3.3 S31P antibody recognized only H3 found in fractions containing the H3.3 variant and failed to react with fractions containing H3.2 and H3.1 .

• Phosphatase treatment: Lambda-phosphatase treatment removes phosphorylation marks and should eliminate antibody reactivity. Tests showed that phosphatase treatment removed essentially all phospho-specific signals seen with H3.3 S31P antibodies .

• Cell cycle specificity: Antibody reactivity should be consistent with the known cell cycle-dependent phosphorylation pattern. Immunoblots with total acid-extracted histones from HeLa cells showed that H3.3 S31 was phosphorylated only in mitotic (nocodazole-arrested) and not in asynchronous growing cells .

What cross-reactivity concerns should researchers be aware of when using Phospho-H3F3A (S31) antibodies?

When using Phospho-H3F3A (S31) antibodies, researchers should be aware of potential cross-reactivity with:

• Other phosphorylation sites on histone H3: Some antibodies might recognize similar phosphorylation motifs, particularly H3 S28P, which can be phosphorylated simultaneously. Peptide competition assays using various phosphorylated H3 peptides are essential to confirm specificity .

• H3F3B paralog: H3F3A and H3F3B encode identical proteins (H3.3), so antibodies will recognize the phosphorylated form of both gene products. This is usually not problematic as they are functionally equivalent, but should be considered when interpreting genetic experiments .

• Non-specific binding in complex samples: In tissue sections or whole cell lysates, validation through knockout controls, phosphatase treatment, or mitotic enrichment is recommended to ensure signal specificity .

What are the optimal dilutions and conditions for using Phospho-H3F3A (S31) antibodies in different applications?

Based on the search results, the recommended dilutions and conditions for Phospho-H3F3A (S31) antibodies vary by application:

For optimal results, using samples enriched for mitotic cells (e.g., nocodazole treatment for 18 hours at 100 ng/ml) significantly enhances detection of H3.3 S31 phosphorylation .

How can researchers design co-immunostaining experiments with Phospho-H3F3A (S31) antibodies to study cell cycle progression?

For effective co-immunostaining experiments studying cell cycle progression:

• Sample preparation: Fix cells using 4% paraformaldehyde and permeabilize with 0.1% Triton X-100. For tissue sections, use heat-mediated antigen retrieval with citrate buffer pH 6 .

• Antibody selection: Combine Phospho-H3F3A (S31) antibody with other cell cycle markers:

  • Aurora-B kinase antibody to mark centromeres and the mitotic spindle

  • CENP-A S7P antibody to mark early prophase

  • H3 S10P/S28P antibodies to differentiate early versus late mitotic stages

  • DAPI for DNA visualization

• Staining protocol: For dual staining, use:

  • Primary antibodies from different species (e.g., rabbit anti-H3.3 S31P with mouse anti-Aurora-B)

  • Species-specific secondary antibodies with distinct fluorophores (e.g., Alexa Fluor 488 and Alexa Fluor 594)

  • Sequential incubation if both primary antibodies are from the same species

• Imaging and analysis: Use confocal microscopy for optimal resolution. Look for:

  • Co-localization patterns in different mitotic stages

  • Temporal relationships between different phosphorylation events

  • Speckled staining of H3.3 S31P in the dense region of the metaphase plate

How does H3.3 S31 phosphorylation contribute to heterochromatin formation?

H3.3 S31 phosphorylation plays a critical role in heterochromatin formation through regulation of the H3K9/K36 histone demethylase KDM4B. Studies in mouse embryonic stem (ES) cells reveal:

• Regulation of heterochromatin accessibility: H3.3 S31 phosphorylation controls heterochromatin accessibility at telomeres during replication through inhibition of KDM4B activity .

• Maintenance of H3K9 methylation: When S31 is phosphorylated or substituted with glutamic acid (S31E) to mimic phosphorylation, it inhibits KDM4B, leading to increased H3K9me3 levels at heterochromatic regions .

• Genomic stability: Absence of S31 phosphorylation (as in S31A mutants) results in increased KDM4B activity that removes H3K9me3 from telomeres, potentially compromising heterochromatin integrity .

• Protection of repetitive DNA: H3.3 S31 phosphorylation helps preserve chromatin integrity at repetitive DNA sequences, including telomeres, pericentric heterochromatin, and Y chromosome-specific satellite DNA repeats .

These findings suggest that H3.3 S31 phosphorylation serves as a regulatory mechanism to control heterochromatin structure and protect genome stability during cell division.

What is the relationship between H3.3 S31 phosphorylation and histone acetyltransferase p300 activity?

H3.3 S31 phosphorylation promotes p300 histone acetyltransferase activity through several mechanisms:

• Enhanced p300 enzymatic activity: In vitro experiments show that phosphorylated H3.3-containing nucleosomes stimulate p300 activity, resulting in higher levels of histone acetylation compared to unphosphorylated substrates .

• Specificity to H3.3: This stimulatory effect is specific to H3.3, as phosphorylated H3.1 nucleosomes (which contain alanine at position 31) do not show increased p300 activity .

• Recovery of H3K27ac levels: In H3.3 knockout mouse embryonic stem cells (mESCs), expression of H3.3S31E (which mimics phosphorylation) restored H3K27ac levels at enhancers comparable to wild-type mESCs, while H3.3S31A (which cannot be phosphorylated) did not .

• Integration of signaling information: H3.3 phosphorylation provides a "phosphothreshold" for p300 stimulation, allowing H3.3 to act as a nucleosomal cofactor that integrates signaling information into chromatin to promote robust enhancer acetylation .

This relationship highlights how a single amino acid in histone H3.3 can influence global genome regulation by affecting histone acetyltransferase activity.

How can researchers distinguish between the biological effects of H3.3 S31 phosphorylation and other concurrent histone modifications?

To distinguish between the biological effects of H3.3 S31 phosphorylation and other concurrent modifications, researchers can employ several advanced approaches:

• Phospho-mimetic and phospho-deficient mutants: Generate H3.3 mutants where S31 is replaced with:

  • Alanine (S31A) to prevent phosphorylation

  • Glutamic acid (S31E) to mimic constitutive phosphorylation

  Compare these with wild-type H3.3 and canonical H3 in rescue experiments to isolate S31 phosphorylation effects .

• Sequential ChIP (ChIP-reChIP): Perform sequential chromatin immunoprecipitation with antibodies against H3.3 S31P and other modifications (e.g., H3K9me3, H3K27ac) to identify regions where these marks co-occur .

• Mass spectrometry analysis: Use high-resolution mass spectrometry to quantify combinatorial histone modifications on the same histone tail. For example, determining whether S31 phosphorylation occurs simultaneously with or excludes S28 phosphorylation on the same histone molecule .

• In vitro enzyme assays: Test how S31 phosphorylation affects the activity of histone-modifying enzymes like KDM4B and p300 on defined nucleosomal substrates with controlled modification states .

• Cell cycle synchronization: Compare modification patterns in synchronized cell populations at specific cell cycle stages to decouple cell cycle-dependent from cell cycle-independent effects .

What advanced imaging techniques can be used to analyze the spatial-temporal dynamics of H3.3 S31 phosphorylation during mitosis?

Advanced imaging techniques for analyzing H3.3 S31 phosphorylation dynamics include:

• Live-cell imaging with fluorescent protein fusions:

  • Express H3.3-GFP fusion proteins (wild-type or S31A/S31E mutants)

  • Combine with fluorescently tagged cell cycle markers (e.g., PCNA for S phase)

  • Use time-lapse confocal or spinning disk microscopy to track H3.3 dynamics

• Super-resolution microscopy:

  • Stimulated emission depletion (STED) microscopy

  • Structured illumination microscopy (SIM)

  • Photoactivated localization microscopy (PALM)

  These techniques provide resolution beyond the diffraction limit, allowing precise localization of H3.3 S31P within chromatin structures during mitosis .

• Proximity ligation assay (PLA): Detect interactions between H3.3 S31P and other proteins in situ with single-molecule sensitivity to identify potential functional partners during different mitotic phases .

• FRAP (Fluorescence Recovery After Photobleaching): Analyze the mobility and exchange rates of H3.3 at different phosphorylation states during mitotic progression .

• Correlative light and electron microscopy (CLEM): Combine fluorescence imaging of H3.3 S31P with electron microscopy to correlate its distribution with ultrastructural features of mitotic chromosomes .

How can researchers analyze the effects of H3.3 S31 phosphorylation on chromatin accessibility and transcriptional regulation?

To analyze how H3.3 S31 phosphorylation affects chromatin accessibility and transcriptional regulation, researchers can employ these advanced methodologies:

• ATAC-seq with phospho-specific conditions: Compare chromatin accessibility in cells expressing wild-type H3.3 versus S31A or S31E mutants to determine how phosphorylation affects nucleosome organization and DNA accessibility .

• CUT&RUN or CUT&Tag for phospho-histone profiling: Use these techniques for high-resolution mapping of H3.3 S31P distribution across the genome, particularly at heterochromatic regions and transcriptionally active sites .

• Hi-C and micro-C analysis: Examine how H3.3 S31 phosphorylation affects three-dimensional chromatin organization by comparing chromatin interaction maps in cells with normal versus altered H3.3 S31 phosphorylation levels .

• Nascent RNA sequencing: Combine with phospho-mimetic or phospho-deficient H3.3 mutants to directly assess the impact on transcription rather than steady-state RNA levels .

• In vitro transcription systems with defined nucleosomes: Reconstitute chromatin with H3.3-containing nucleosomes that are either phosphorylated at S31 or not, then measure transcriptional output to directly assess the impact of this modification on RNA polymerase activity .

• Sequential ChIP-seq for histone modification co-occurrence: Identify genomic loci where H3.3 S31P co-occurs with activating (H3K27ac, H3K4me3) or repressive (H3K9me3) marks to understand its context-dependent functions .

What are common issues in detecting H3.3 S31 phosphorylation and how can they be addressed?

Researchers frequently encounter several challenges when detecting H3.3 S31 phosphorylation:

• Low signal due to cell cycle specificity: Since H3.3 S31 phosphorylation primarily occurs during late prometaphase and metaphase, asynchronous cell populations may show minimal signal.

  • Solution: Enrich for mitotic cells using nocodazole (100 ng/ml for 18 hours) or other mitotic arrest agents .

• Cross-reactivity with other phosphorylation sites: Some antibodies may detect similar phosphorylation motifs.

  • Solution: Always include peptide competition controls or phosphatase-treated samples to confirm specificity .

• Rapid dephosphorylation during sample preparation: Phosphate groups can be lost during cell lysis and processing.

  • Solution: Include phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate) in all buffers and maintain samples at 4°C throughout processing .

• Variable epitope accessibility in fixed tissues: Formalin fixation can mask the phospho-epitope.

  • Solution: Optimize antigen retrieval conditions; citrate buffer pH 6 with heat-mediated retrieval is recommended for most applications .

• Degradation during storage: Repeated freeze-thaw cycles can affect antibody performance.

  • Solution: Store antibodies at -20°C or -80°C in small aliquots containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide .

How can researchers quantitatively analyze H3.3 S31 phosphorylation levels in different experimental conditions?

For quantitative analysis of H3.3 S31 phosphorylation across experimental conditions, researchers should consider these methodological approaches:

• Flow cytometry:

  • Fix cells with 4% paraformaldehyde and permeabilize with 90% methanol

  • Stain with H3.3 S31P antibody (1:50-1:150 dilution) and appropriate fluorescent secondary antibody

  • Include cell cycle markers (e.g., propidium iodide for DNA content)

  • Analyze using flow cytometry to quantify percentage of positive cells and signal intensity

• Quantitative Western blotting:

  • Load equal amounts of histone extracts (10-15 μg)

  • Include loading controls (total H3 or H3.3)

  • Use fluorescent secondary antibodies for wider linear detection range

  • Analyze band intensities using densitometry software and normalize to loading controls

• ELISA-based approaches:

  • Develop sandwich ELISA with capture antibody against H3.3 and detection antibody against S31P

  • Generate standard curves using recombinant phosphorylated H3.3

  • Analyze samples in triplicate to ensure statistical significance

• Mass spectrometry:

  • Separate histone variants using RP-HPLC

  • Perform targeted mass spectrometry to quantify phosphorylated versus non-phosphorylated peptides

  • Use stable isotope labeling approaches (SILAC) for direct comparison between conditions

• High-content imaging analysis:

  • Stain cells with H3.3 S31P antibody and DNA dye

  • Acquire images using automated microscopy

  • Perform automated image analysis to quantify nuclear signal intensity across cell populations

  • Classify cells by mitotic stage based on DNA morphology